This page contains a Flash digital edition of a book.
Mind & Brain, the Journal of Psychiatry


10. Comings D. Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. II. Alcohol abuse. Drug Alcohol Depend. 1994;35:1724.


11. Comings D, Comings B. A controlled study of Tourette syndrome. II. Conduct. Am J Hum Genet. 1987;41:742760.


12. Comings D, Comings B. A controlled family history study of Tourette Syndrome. II. Alcoholism, drug abuse and obesity. J Clin Psychiatr. 1990;51:281287.


13. Marks I. Behavioral (non-chemical) addiction. Br J Addict. 1990;85:1389 1394.


14. Miller L. Tourette syndrome and drug addiction. Br J Psychiatry. 1985;147:584585.


15. Goudriaan A, Oosteriaan J, de Beurs E, van den Brink W. Neurocognitive functions in pathological gambling: a comparison with alcohol depen- dence, Tourette syndrome and normal controls. Addiction. 2006;101:534 547.


16. Pani P, Maremmani I, Trogu E, Gessa GL, Ruiz P, Akiskal HS. Delineating the psychic structure of substance abuse and addictions: should anxiety, mood and impulse-control dysregulation be included? J Affect Disord. 2010;122:185197.


17. Daniels J, Baker D, Norman A. Cocaine-induced tics in untreated Tourette’s syndrome. Am J Psychiatry. 1996;153:965.


18. Muller-Vahl K. Cannabinoids reduce symptoms of Tourette’s syndrome. Expert Opin Pharmacother. 2003;4:17171725.


19. Lagerkvist B. [Peter the Great and Tourette syndrome. Impulsive, violent sovereign who drank a lot of alcohol to control his tics.]. Lakartidningen. 2005;102:14401441, 1443.


20. Goetz C. Clonidine and clonazepam in Tourette syndrome. Adv Neurol. 1992;58:245251.


21. Negrete J, Collins J, Turner NE, Skinner W. The centre for addiction and mental health concurrent disorders screener. Can J Psychiatry. 2004;49:843850.


22. American Psychiatric Association. Diagnostic and Statistical manual of mental disorders DSM-IV-TR Fourth edition. Washington DC: American Psychiatric Association, 2000.


23. Barkley R, Murphy K, Fischer M. Identifying new symptoms for ADHD in adulthood. In: Barkley R, Murphy K, Fisher M, eds. ADHD in Adults: What the Science Tells Us. New York: Guilford Press; 2008:170204.


24. Budman C, Rockmore L, Stokes J, Sossin M. Clinical phenomenology of episodic rage in children with Tourette syndrome. J Psychosom Res. 2003;55:5965.


25. Leckman J, Riddle M, Hardin M, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28:566573.


26. Goodman W, Price L, Rasmussen S, et al. The Yale-Brown Obsessive- Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46:10061011.


27. Leckman J, Towbin K,Ort S, et al. Clinical assessment of tic disorder severity. In: Cohen DJ, Bruhn RD, Leckman J, eds. , Tourette’s Syndrome and Tic Disorders: Clinical Understanding and Treatment. New York: John Wiley and Sons; 1988:5578.


28. Compton W, Thomas Y, Stinson F, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64(5):566576.


29. Matthew C, Waller J, Glidden D, et al. Self injurious behavior in Tourette syndrome: correlates with impulsivity and impulse control. J Neurol Neurosurg Psychiatry. 2004;75:11491155.


30. Johnson C, Drgon T, McMahon F, Uhl GR. Convergent genome wide association results for bipolar disorder and substance dependence. Am J Med Genet Part B. 2009;150B:182190.


31. Krishnan K. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med. 2005;67(1):18.


32. McTague A, Appleton R. Episodic dyscontrol syndrome. Arch Dis Child. 2010; 95: 84142.


33. Budman C, Bruun R, Park K, Olson ME. Rage attacks in children and adolescents with Tourette’s disorder: a pilot study. J Clin Psychiatry. 1998;59:576580.


M&B 2011; 2:(1). July 2011 14


34. Budman C, Bruun R, Park K, Lesser M, Olson ME. Explosive outbursts in children with Tourette’s disorder. J Am Acad Child Adolesc Psychiatry. 2000;39:12701276.


35. Hechtman L, Weiss G. Controlled prospective fifteen year follow-up of hyperactives as adults: non-medical drug and alcohol use and anti-social behavior. Can J Psychiatry. 1986;31:557567.


36. Kessler R, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163:716723.


37. Biederman J, Petty C, Wilens T, et al. Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders. Am J Psychiatry. 2008;165:107115.


38. Tarter R, Kirisci L, Mezzich A, et al. Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am J Psychiatry. 2003;160(6):10781085.


39. Grant J, Potenza M, Weinstein A, Gorelick DA. Introduction to behavioral addictions. Am J Drug Alcohol Abuse. 2010;36:266241.


40. Hollander E. Behavioral and substance addictions: a new proposed DSM- V category characterized by impulsive choice, reward sensitivity, and frontostriatal circuit impairment. CNS Spectr. 2006;11(11):814.


41. Potenza M. Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philos Trans R Soc Lond B Biol Sci. 2008;363(1507):31813189.


42. Potenza M. Should addictive disorders include non-substance-related conditions? Addiction. 2006;101(Suppl. 1):142151.


43. Potenza M, Koran L, Pallanti S. The relationship between impulse- control disorders and obsessive-compulsive disorder: a current under- standing and future research directions. Psychiatry Res. 2009;170(1):2231.


44. Fineberg N, Potenza M, Chamberlain S, et al. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology. 2010;35(3):591604.


45. Hollander E, Kim S, Braun A, Simeon D, Zohar J. Cross-cutting issues and future directions for the OCD spectrum. Psychiatry Res. 2009;170(1):36.


46. Haber S. Parallel and integrative processing through the basal ganglia reward circuit: lessons from addiction. Biol Psychiatry. 2008;64:173174.


47. Singer H, Wendlandt J. Neurochemistry and synaptic neurotransmission in Tourette syndrome. Adv Neurol. 2001;85:163178.


48. Fareri D, Martin L, Delgado M. Reward-related processing in the human brain: developmental considerations. Dev. Psychopathol. 2008;20(4):1191 1211.


49. Marsh R, Maia T, Peterson B. Functional disturbances within frontos- triatal circuits across multiple childhood psychopathologies. Am J Psychiatry. 2009;166(6):664674.


50. Albin R. Neurobiology of basal ganglia and Tourette syndrome: striatal and dopamine function. Adv Neurol. 2006;99:99106.


51. Braun AR, Stoetter B, Randolph C, et al. The functional neuroanatomy of Tourette’s syndrome: an FDG-PET study. 1. Regional changes in cerebral glucose metabolism differentiating patients and controls. Neuropsycho- pharmacology. 1993;9:277291.


52. Eidelberg D, Moeller JR, Antonini A, et al. The metabolic anatomy of Tourette’s syndrome. Neurology. 1997;48:927934.


53. Singer H, Szymanski S, Giuliano J, et al. Elevated intrasynaptic dopamine release in Tourette’s syndrome measured by PET. Am J Psychiatry. 2002;159:13291336.


54. Albin R, Koeppe R, Bohnen N, et al. Increased ventral striatal monoaminergic innervation in Tourette syndrome. 2003;61:310315.


Neurology.


55. Butler T, Stern E, Silbersweig D. Functional neuroimaging of Tourette syndrome: advances and future directions. Adv Neurol. 2006;99:115129.


56. Sowell E, Kan E, Yoshii J, et al. Thinning of sensorimotor cortices in children with Tourette syndrome. Nat Neurosci. 2008;11(6):637639.


57. Saxena S, Bota R, Brody A. Brain-behavior relationships in obsessive- compulsive disorder. Semin Clin Neuropsychiatry. 2001;6:82101.


58. Braun AR, Randolph C, Stoetter B, et al. The functional neuroanatomy of Tourette’s syndrome: an FDG-PET study. II: relationships between regional cerebral metabolism and associated behavioral and cognitive features of the illness. Neuropsychopharmacology. 1995;9:277291.


www.slm-psychiatry.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89